júlí 2005

7/05
(21) 7897
(22) 20.6.2005
(41) 20.6.2005
(51) A61K 31/00; A61K 31/44; A61K
31/501; A61K 31/522; A61P 3/00
(54) PDE4 og PDE3/4 tálmar til notkunar
í meðhöndlun á kröm.
(71) Altana Pharma AG, Byk-Gulden-
Str. 2, 78467 Konstanz, Þýskalandi.
(72) Mathias Schmidt, Konstanz,
Þýskalandi.
(74) Sigurjónsson & Thor, ehf.,
Skólavörðustíg 16, 101 Reykjavík.
(30) 27.11.2002, EP, 02026548.4
(85) 20.6.2005
(86) 26.11.2003, PCT/EP2003/013313
(21) 7898
(22) 20.6.2005
(41) 20.6.2005
(51) A61K 31/167; A61K 31/44; A61P
11/00
(54) Ný samverkandi samsetning sem
felur í sér róflúmílast og formóteról.
(71) Altana Pharma AG, Byk-Gulden-
Str. 2, 78467 Konstanz, Þýskalandi.
(72) Rolf Beume, Konstanz, Þýskalandi;
Daniela Bundschuh, Ermatingen,
Sviss; Norbert Kolassa, Konstanz,
Þýskalandi; Degenhard Marx, Moos,
Þýskalandi; Christian Weimar,
Konstanz, Þýskalandi.
(74) Sigurjónsson & Thor, ehf.,
Skólavörðustíg 16, 101 Reykjavík.
(30) 27.11.2002, EP, 02026505.4
(85) 20.6.2005
(86) 26.11.2003, PCT/EP2003/013275
(21) 7899
(22) 20.6.2005
(41) 20.6.2005
(51) A61K 31/167; A61K 31/44; A61P
11/00
(54) Samverkandi samsetning sem felur
í sér róflúmílast og (R.R)-formóteról.
(71) Altana Pharma AG, Byk-Gulden-
Str. 2, 78467 Konstanz, Þýskalandi.
(72) Rolf Beume, Konstanz, Þýskalandi;
Daniela Bundschuh, Ermatingen,
Sviss; Degenhard Marx, Moos,
Þýskalandi; Christian Weimar,
Konstanz, Þýskalandi; Stefan-Lutz
Wollin, Meersburg, Þýskalandi.
(74) Sigurjónsson & Thor, ehf.,
Skólavörðustíg 16, 101 Reykjavík.
(30) 27.11.2002, EP, 02026504.7
(85) 20.6.2005
(86) 26.11.2003, PCT/EP2003/013266
(21) 7900
(22) 20.6.2005
(41) 20.6.2005
(51) A61K 39/395
(54) Efni sem verka á viðtaka beta
eitilfrumueiturs saman með
efnameðferðarefnum.
(71) Biogen Idec MA, Inc., 14
Cambridge Center, Cambridge,
Massachusetts 02142, Bandaríkjunum.
ELS tíðindi 63
(72) Doreen Lepage, Pascoag, Rhode
Island; Alan Gill, Reading,
Massachusetts; Bandaríkjunum.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Lynghálsi 4, 110 Reykjavík.
(30) 20.12.2002, US, 60/435,185
(85) 20.6.2005
(86) 22.12.2003, PCT/US2003/041243
(21) 7901
(22) 20.6.2005
(41) 20.6.2005
(51) A61K 31/451; A61K 31/4418; C07D
211/22; C07D 211/70; C07D 407/12;
A61P 25/00
(54) 4-(2-Fenýloxýfenýl)-píperidín eða -
1,2,3,6-tetrahýdrópýridín afleiður
sem serótónín endurupptöku hindrar.
(71) H. Lundbeck A/S, 9, Ottiliavej, DK-
2500 Valby-Copenhagen, Danmörku.
(72) Benny Bang-Andersen, Copenhagen;
Friedrich Kroll, Valby; Jan Kehler,
Lyngby; Danmörku.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 4.4.2003, DK, PA 2003 00519
(85) 20.6.2005
(86) 2.4.2004, PCT/DK04/000241
(21) 7902
(22) 20.6.2005
(41) 20.6.2005
(51) A61K 7/48; A61K 7/50
(54) Blettaeyðandi samsetning fyrir
húðumhirðu.
(71) St. Tropez, Inc., 27334 Muirfield
Lane, Valencia, California 91355,
Bandaríkjunum.
(72) Kari Serruys, Chatsworth, California,
Bandríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 20.12.2002, US, 60/435,411
(85) 20.6.2005
(86) 19.12.2003, PCT/US03/041208
(21) 7903
(22) 20.6.2005
(41) 20.6.2005
(51) A01K 73/02
(54) Trollbúnaður.
(71) Aker Seafoods Holding AS,
Fjordalleen 16, N-0250 Oslo, Noregi.
(72) Robert Ernsten, Golfito, Costa Rica;
Roar Arskog, Ørsta, Noregi; Jan H.
Kjærstad, Søvik, Noregi; Børge
Nakken, Fiksdal, Noregi.
(74) A&P Árnason ehf., Efstaleiti 5, 103
Reykjavík.
(30) 15.7.2003, NO, 20033198
(85) 20.6.2005
(86) 13.7.2004, PCT/NO2004/000215
(21) 7905
(22) 22.6.2005
(41) 22.6.2005
(51) C07D 207/14
(54) 3-amínópýrrólídínafleiður sem
bólguboðaviðtakastillar.
(71) Incyte Corporation, Experimental
Station, Building 336, Rt. 141 &
Henry Clay Road, Wilmington,
Delaware 19880, Bandaríkjunum.
(72) Chu-Biao Xue, Hockessin,
Delaware; Brian Metcalf, Moraga,
California; Hao Feng, Aston,
Pennsylvania; Ganfeng Cao,
Newark, Delaware; Taishing Huang,
Wilmington, Delaware; Changsheng
Zheng, Wilmington, Delaware;
Darius J. Robinson, Wilmington,
Delaware; Amy Qi Han, Hockessin,
Delaware; Bandaríkjunum.
(74) Sigurjónsson & Thor, ehf.,
Skólavörðustíg 16, 101 Reykjavík.
(30) 27.11.2002, US, 60/429,605
18.4.2003, US, 60/463,976
(85) 22.6.2005
(86) 26.11.2003, PCT/US2003/037946
(21) 7906
(22) 22.6.2005
(41) 22.6.2005
(51) A61K 31/428; C07D 277/82
(54) Afleiður própargýl-tríflúorómetoxýamínó-benzóþíazóls.
(71) Teva Pharmaceutical Industries,
LTD., 5 Basel Street, P.O. Box 3190,
Petach-Tikva 49131, Ísrael.
(72) Jeffrey Sterling, Jerusalem; Liat
Hayardeny, Tel Aviv; Ellezer Flab,
Givatzim; Yaacov Herzig, Raanana;
David Lerner, Jerusalem; Ísrael.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Lynghálsi 4, 110 Reykjavík.
(30) 21.11.2002, US, 10/301,540
(85) 22.6.2005
(86) 20.11.2003, PCT/US2003/037592
(21) 7907
(22) 22.6.2005
(41) 22.6.2005
(51) A61K 31/18; C07D 311/21
(54) Astmi og stillar ofnæmisbólgu.
(71) Tularik, Inc., 1120 Veterans
Boulevard, South San Francisco,
California 94080, Bandaríkjunum.
(72) Zice Fu, Burlingame; Xi Alan Huang,
San Mateo; Jiwen Liu, Foster City;
Julio C. Medina, San Carlos; Lucy
H. Tang, San Francisco; Yingcai
Wang, San Mateo; Qingge Xu,
Burlingame; California, Bandaríkjunum.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Lynghálsi 4, 110 Reykjavík.
(30) 20.12.2002, US, 60/435,366
(85) 22.6.2005
(86) 19.12.2003, PCT/US2003/040617
(21) 7908
(22) 23.6.2005
(41) 23.6.2005
(51) A61K 31/721; A61K 37/06
(54) Ný notkun dextransúlfats.
(71) ProphyMed AB, Box 81, SE-260 40
Viken, Svíþjóð.
(72) Bo Nilsson; Olle Korsgren; Uppsala,
Svíþjóð.
(74) Sigurjónsson & Thor, ehf.,
Skólavörðustíg 16, 101 Reykjavík.
(30) 28.11.2002, SE, 0203526-9
(85) 23.6.2005
(86) 26.11.2003, PCT/SE2003/001830